A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients
Häberle L, Erber R, Gaß P, Hein A, Jud S, Langemann H, Rauh C, Hack C, Schulz-Wendtland R, Hartmann A, Beckmann M, Lux MP, Fasching P (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Publisher: OXFORD UNIV PRESS
City/Town: OXFORD
Conference Proceedings Title: ANNALS OF ONCOLOGY
Event location: Munich
DOI: 10.1093/annonc/mdy270.221
Authors with CRIS profile
Ramona Erber
Institute of Pathology
Paul Gaß
Department of Obstetrics and Gynaecology
Alexander Hein
Department of Obstetrics and Gynaecology
Sebastian Jud
Department of Obstetrics and Gynaecology
Hanna Langemann
Department of Obstetrics and Gynaecology
Caroline Hack
Professur für Ethik in der Medizin
Arndt Hartmann
Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie
Matthias Beckmann
Lehrstuhl für Geburtshilfe und Frauenheilkunde
Peter Fasching
Professur für Translationale Frauenheilkunde und Geburtshilfe
How to cite
APA:
Häberle, L., Erber, R., Gaß, P., Hein, A., Jud, S., Langemann, H.,... Fasching, P. (2018). A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients. In ANNALS OF ONCOLOGY. Munich, DE: OXFORD: OXFORD UNIV PRESS.
MLA:
Häberle, Lothar, et al. "A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients." Proceedings of the 43rd ESMO Congress (ESMO), Munich OXFORD: OXFORD UNIV PRESS, 2018.
BibTeX: Download